DE68913907D1 - Methode zur Behandlung des interstitiellen Blasenentzündung. - Google Patents
Methode zur Behandlung des interstitiellen Blasenentzündung.Info
- Publication number
- DE68913907D1 DE68913907D1 DE89311177T DE68913907T DE68913907D1 DE 68913907 D1 DE68913907 D1 DE 68913907D1 DE 89311177 T DE89311177 T DE 89311177T DE 68913907 T DE68913907 T DE 68913907T DE 68913907 D1 DE68913907 D1 DE 68913907D1
- Authority
- DE
- Germany
- Prior art keywords
- interstitial cystitis
- treating interstitial
- naltrexone
- nalmefene
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 208000005615 Interstitial Cystitis Diseases 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- WJBLNOPPDWQMCH-MBPVOVBZSA-N Nalmefene Chemical compound N1([C@@H]2CC3=CC=C(C=4O[C@@H]5[C@](C3=4)([C@]2(CCC5=C)O)CC1)O)CC1CC1 WJBLNOPPDWQMCH-MBPVOVBZSA-N 0.000 abstract 2
- 229960005297 nalmefene Drugs 0.000 abstract 2
- 229960003086 naltrexone Drugs 0.000 abstract 2
- DQCKKXVULJGBQN-XFWGSAIBSA-N naltrexone Chemical compound N1([C@@H]2CC3=CC=C(C=4O[C@@H]5[C@](C3=4)([C@]2(CCC5=O)O)CC1)O)CC1CC1 DQCKKXVULJGBQN-XFWGSAIBSA-N 0.000 abstract 2
- 239000003887 narcotic antagonist Substances 0.000 abstract 1
- 238000007911 parenteral administration Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Threshing Machine Elements (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/265,575 US4877791A (en) | 1988-11-01 | 1988-11-01 | Method of treatment for interestitial cystitis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE68913907D1 true DE68913907D1 (de) | 1994-04-21 |
| DE68913907T2 DE68913907T2 (de) | 1994-06-23 |
Family
ID=23011021
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE68913907T Expired - Fee Related DE68913907T2 (de) | 1988-11-01 | 1989-10-30 | Methode zur Behandlung des interstitiellen Blasenentzündung. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US4877791A (de) |
| EP (1) | EP0367533B1 (de) |
| JP (1) | JPH07556B2 (de) |
| AT (1) | ATE102830T1 (de) |
| AU (1) | AU623189B2 (de) |
| CA (1) | CA2001996C (de) |
| DE (1) | DE68913907T2 (de) |
| DK (1) | DK541189A (de) |
| HK (1) | HK119994A (de) |
| NO (1) | NO894295L (de) |
| ZA (1) | ZA897823B (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4857533A (en) * | 1988-12-15 | 1989-08-15 | Baker Cummins Pharmaceuticals, Inc. | Method of treatment for autoimmune diseases |
| US4994466A (en) * | 1990-06-14 | 1991-02-19 | Baker Cummins Pharmaceuticals, Inc. | Method of treatment for multiple sclerosis |
| US5057322A (en) * | 1990-08-10 | 1991-10-15 | Baker Cummins Dermatologicals, Inc. | Method of treating mast cell disease |
| US5145859A (en) * | 1991-03-20 | 1992-09-08 | Case Western Reserve University | Methods of treating interstitial cystitis and urethral syndrome |
| JP3348230B2 (ja) | 1995-03-03 | 2002-11-20 | アルゴス ファーマシューティカル コーポレーション | 尿失禁の治療用のデキシトルメトルファン又はデキシトルオルファンの使用 |
| US5878750A (en) * | 1996-11-14 | 1999-03-09 | Clemens; Anton H. | Method of treating the syndrome of coronary heart disease risk factors in humans |
| US6203813B1 (en) | 1997-01-13 | 2001-03-20 | Lance L. Gooberman | Pharmaceutical delivery device and method of preparation therefor |
| WO2000044390A1 (en) * | 1999-02-01 | 2000-08-03 | John Lezdey | Treatment of bladder and gastrointestinal mastocytosis |
| US6528520B2 (en) | 2000-08-15 | 2003-03-04 | Cpd, Llc | Method of treating the syndrome of coronary heart disease risk factors in humans |
| US6846831B2 (en) | 2000-08-15 | 2005-01-25 | Cpd, Llc | Method of treating the syndrome of lipodystrophy |
| US6262062B1 (en) | 2000-08-15 | 2001-07-17 | Cpd, Llc | Method of treating the syndrome of coronary heart disease risk factors in humans |
| WO2002081477A1 (fr) * | 2001-03-30 | 2002-10-17 | Toray Industries, Inc. | Derives morphinane 7-substitues et leur utilisation medicinale |
| US7501433B2 (en) * | 2002-05-17 | 2009-03-10 | Jenken Biosciences, Inc. | Opioid and opioid-like compounds and uses thereof |
| US6972291B2 (en) * | 2002-07-02 | 2005-12-06 | Bernstein Richard K | Method for reducing food intake |
| US8017622B2 (en) * | 2003-05-16 | 2011-09-13 | Jenken Biosciences, Inc. | Opioid and opioid-like compounds and uses thereof |
| PT2010220T (pt) * | 2006-04-03 | 2022-05-20 | Ceva Animal Health Pty Ltd | Formulações de polisulfato de pentosano estabilizado (pps) |
| EP2365759B1 (de) * | 2008-12-16 | 2018-03-07 | Hill's Pet Nutrition, Inc. | Antioxidantienhaltige nahrungsmittelzusammensetzung zur hemmung von histamin-signalwegen bei haustieren |
| WO2019227053A1 (en) * | 2018-05-25 | 2019-11-28 | Adamis Pharmaceuticals Corporation | Drug compositions |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU538186B2 (en) * | 1980-03-07 | 1984-08-02 | Scotia Holdings Plc | Prostaglandin precursors |
| JPS63501717A (ja) * | 1985-10-29 | 1988-07-14 | ベーカー・カミンス・デルマトロジカルス・インコーポレーテッド | 抗原誘発性アレルギ−反応を阻止するための方法および組成物 |
| FR2609632B1 (fr) * | 1987-01-21 | 1991-03-29 | Shelly Marc | Nouvelle application therapeutique de la 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinon-6-one et les compositions pharmaceutiques destinees a cet usage |
| US4880813A (en) * | 1988-07-22 | 1989-11-14 | Baker Cummins Pharmaceuticals, Inc. | Method of treatment for allergic rhinitis |
| US4857533A (en) * | 1988-12-15 | 1989-08-15 | Baker Cummins Pharmaceuticals, Inc. | Method of treatment for autoimmune diseases |
-
1988
- 1988-11-01 US US07/265,575 patent/US4877791A/en not_active Expired - Fee Related
-
1989
- 1989-10-16 ZA ZA897823A patent/ZA897823B/xx unknown
- 1989-10-25 JP JP1279638A patent/JPH07556B2/ja not_active Expired - Lifetime
- 1989-10-27 NO NO89894295A patent/NO894295L/no unknown
- 1989-10-27 AU AU43850/89A patent/AU623189B2/en not_active Ceased
- 1989-10-30 EP EP89311177A patent/EP0367533B1/de not_active Expired - Lifetime
- 1989-10-30 DK DK541189A patent/DK541189A/da not_active Application Discontinuation
- 1989-10-30 DE DE68913907T patent/DE68913907T2/de not_active Expired - Fee Related
- 1989-10-30 AT AT89311177T patent/ATE102830T1/de not_active IP Right Cessation
- 1989-11-01 CA CA002001996A patent/CA2001996C/en not_active Expired - Fee Related
-
1994
- 1994-11-03 HK HK119994A patent/HK119994A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JPH02188525A (ja) | 1990-07-24 |
| DK541189D0 (da) | 1989-10-30 |
| JPH07556B2 (ja) | 1995-01-11 |
| NO894295D0 (no) | 1989-10-27 |
| HK119994A (en) | 1994-11-11 |
| ATE102830T1 (de) | 1994-04-15 |
| EP0367533A2 (de) | 1990-05-09 |
| EP0367533B1 (de) | 1994-03-16 |
| DK541189A (da) | 1990-05-02 |
| EP0367533A3 (de) | 1991-10-02 |
| DE68913907T2 (de) | 1994-06-23 |
| US4877791A (en) | 1989-10-31 |
| AU623189B2 (en) | 1992-05-07 |
| ZA897823B (en) | 1990-07-25 |
| CA2001996A1 (en) | 1990-05-01 |
| CA2001996C (en) | 1996-07-23 |
| NO894295L (no) | 1990-05-02 |
| AU4385089A (en) | 1990-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE107508T1 (de) | Verwendung von nalmefen oder naltrexon bei der behandlung von autoimmunerkrankungen. | |
| DE68913907D1 (de) | Methode zur Behandlung des interstitiellen Blasenentzündung. | |
| EP0377272A3 (de) | Verwendung von Nalmefen oder Naltrexon zur Herstellung eines Arzneimittels zur Entzündungsbehandlung der Arthritis und assoziierter entzündlicher Erkrankungen | |
| ATE105482T1 (de) | Behandlung von krebs mit somatostatin und mit analogen davon. | |
| PH23867A (en) | Method of treating parkinson's disease using indolone derivatives | |
| DE69210654D1 (de) | Verwendung von Tomoxetine zur Behandlung von Funktionsstörungen der niedrigen Harnwege | |
| DE69201660T2 (de) | Verwendung von Acetyl L-Carnitin zur therapeutischen Behandlung von Coma. | |
| ATE78687T1 (de) | Quaternaere derivate von noroxymorphon zur behandlung von uebelkeit und erbrechen. | |
| ES2093357T3 (es) | Metodo de tratamiento de la alopecia. | |
| EP0319962A3 (de) | Piperidinyl-Methanol-Derivate zur Behandlung von Angstzuständen | |
| GR3025518T3 (en) | Use of the N-n-butyl derivative of desoxynojirimycin in the manufacture of a medicament inhibiting HIV-Virus | |
| DE69113921T2 (de) | Verwendung eines reinen Opiatantagonisten, z.B. Nalmefen, Naltrexon, Naloxon oder Diprenorphin, zur Behandlung von Mastzell-Erkrankungen. | |
| IT9086204A0 (it) | Metodo per la cura dell'impotenza erettiva maschile | |
| DE345883T1 (de) | Verwendung von dapiprazol zur herstellung eines arzneimittels zur verhinderung des toleranzentwicklung bei der analgetischen behandlung mit morphin. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |